Supplement × Prescription·a conflict·Moderate evidence

Roflumilast + St. John's Wort

Conflict Moderate evidence

St. John's Wort can induce CYP3A4 and may reduce roflumilast exposure, potentially decreasing COPD exacerbation prevention.

From the database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, and the recommendation.

Pair type
Conflict
Evidence
Moderate
Source citations
1
Scope
Supplement × Prescription
Last verified
June 4, 2026
ConflictModerate evidence

What is happening. St. John's Wort can induce CYP3A4 and may reduce roflumilast exposure, potentially decreasing COPD exacerbation prevention.

Mechanism. CYP3A4 induction can lower roflumilast and active metabolite exposure.

Recommendation. Avoid St. John's Wort unless the prescriber specifically approves and monitors clinical response.

Stack Score

How it moves the number.

Effect on the composite score

If both Roflumilast and St. John's Wort are in the same stack, this pair applies −10 to your Stack Score (per scored conflict row).

The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.

Sources

Sources, by evidence tier.

Every claim on this page is cited. PMIDs link straight to PubMed.

Reference material

1
  • 1U.S. National Library of Medicine. Roflumilast Tablets US Prescribing Information. 2026.Needs sourceNo link

Check your full routine

One pair was the worked example.

Drop your supplements and prescriptions into NutriStack and it runs every pair at once: every interaction, synergy, timing rule, and contraindication, each linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.